Matthew Shea
Stock Analyst at Needham
(2.55)
# 3,506
Out of 5,182 analysts
5
Total ratings
80%
Success rate
13.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Shea
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TOI The Oncology Institute | Reiterates: Buy | $5 | $3.54 | +41.24% | 3 | Mar 13, 2026 | |
| EVH Evolent Health | Maintains: Buy | $15 → $4 | $2.84 | +40.85% | 1 | Feb 25, 2026 | |
| ASTH Astrana Health | Initiates: Buy | $28 | $31.50 | -11.11% | 1 | Dec 12, 2025 |
The Oncology Institute
Mar 13, 2026
Reiterates: Buy
Price Target: $5
Current: $3.54
Upside: +41.24%
Evolent Health
Feb 25, 2026
Maintains: Buy
Price Target: $15 → $4
Current: $2.84
Upside: +40.85%
Astrana Health
Dec 12, 2025
Initiates: Buy
Price Target: $28
Current: $31.50
Upside: -11.11%